Resveratrol for Alzheimer's disease.
Resveratrol for Alzheimer's disease.
复制标题
DOI:
10.1111/nyas.13431
复制
发表时间:
2017-09
影响因子:
5.2
通讯作者:
Turner RS
中科院分区:
文献类型:
--
作者:
Sawda C;Moussa C;Turner RS
The amyloid hypothesis suggests that the progressive accumulation and deposition of central nervous system amyloid with aging is the proximate cause of Alzheimer’s disease (AD). Thus, targeting molecular mechanisms of aging may represent a viable treatment approach. Caloric restriction prevents diseases of aging, including AD, in animal models, perhaps by activation of sirtuins. The sirtuins (such as mammalian SIRT1) are deacetylases that link energy balance (NAD+/NADH) to regulation of gene transcription. Resveratrol is a potent activator of SIRT1, and thus may mimic caloric restriction to prevent diseases of aging. We conducted a randomized, double blind, placebo-controlled, phase II trial of resveratrol for individuals with mild to moderate AD. Resveratrol (1) is detectable in cerebrospinal fluid (at low nanomolar levels), (2) is safe and well tolerated, (3) alters AD biomarker trajectories, (4) preserves blood–brain barrier integrity, and (5) modulates the CNS immune response. Further studies are needed to determine the safety and efficacy of resveratrol and the validity of this approach in the treatment and prevention of AD and other diseases of aging.
登录
查看更多内容
影响因子:
11.2
作者:
FRATIGLIONI, L;AHLBOM, A;WINBLAD, B
通讯作者:
WINBLAD, B
DOI:
10.1523/jneurosci.5657-12.2013
发表时间:
2013-05-22
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Gräff J;Kahn M;Samiei A;Gao J;Ota KT;Rei D;Tsai LH
通讯作者:
Tsai LH
影响因子:
9.9
作者:
Hebert, L. E.;Bienias, J. L.;Evans, D. A.
通讯作者:
Evans, D. A.
影响因子:
15.9
作者:
Dubois, B;Masure, S;Arnold, B
通讯作者:
Arnold, B
影响因子:
3.5
作者:
Hussain, I;Powell, D;Christie, G
通讯作者:
Christie, G